A growing chorus, including the Trump administration, is calling for a rethinking of after-the-fact drug discounts that some say contribute to rising prices.
Published: July 27, 2018 at 02:00AM
from NYT Health https://ift.tt/2LUYYlG
A growing chorus, including the Trump administration, is calling for a rethinking of after-the-fact drug discounts that some say contribute to rising prices.
Published: July 27, 2018 at 02:00AM
from NYT Health https://ift.tt/2LUYYlG